In a previous publication expression of these modules in patients receiving exogenous IFN-α and IFN-β for hepatitis C and multiple sclerosis respectively suggested that module M1.2 was responsive only to IFN-α and modules M3.4 and M5.12 were also responsive to IFN-β6. This evidence concerns the gene IFNB1 and multiple sclerosis.